Diversity screening versus focussed screening in drug discovery.
about
An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope RecognitionEstimation of the size of drug-like chemical space based on GDB-17 data.High-throughput screening for kinase inhibitors.Highly parallel translation of DNA sequences into small molecules.Review: tubulin function, action of antitubulin drugs, and new drug development.GSA: a GPU-accelerated structure similarity algorithm and its application in progressive virtual screening.Targeting approaches to oral drug delivery.Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry.Perspectives on NMR in drug discovery: a technique comes of ageSmall-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.Composing compound libraries for hit discovery--rationality-driven preselection or random choice by structural diversity?ESI-IMS-MS: A method for rapid analysis of protein aggregation and its inhibition by small molecules.The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond.Origin and evolution of high throughput screening.Biofocussed chemoprospecting: An efficient approach for drug discovery.Microfluidic systems for high-throughput and high-content screening using the nematode Caenorhabditis elegans.Identifying ligands at orphan GPCRs: current status using structure-based approaches.Symmetric kv1.5 blockers discovered by focused screening.Chemoinformatics Research at the University of Sheffield: A History and Citation AnalysisDemonstrating enhanced throughput of RapidFire mass spectrometry through multiplexing using the JmjD2d demethylase as a model system."Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.Label-free measurements of reaction kinetics using a droplet-based optofluidic device.USING CHEMOINFORMATICS TOOLS TO ANALYZE CHEMICAL ARRAYS IN LEAD OPTIMIZATION
P2860
Q27675104-CB4C364E-8C23-4806-AB37-7A94AE6579DBQ30662631-FB00E64D-DF81-4B74-BD98-EA821A568CA5Q31150791-0282DB9C-5545-4455-A3E8-9ED6B3502408Q34221094-E28C0BF6-3EA6-4917-8BD5-7DE6D8A86D4FQ34425460-C737E9C8-49D4-4ED9-847D-416468D845E5Q34451766-6B1D0737-CDB3-49FB-AF1F-753267A93B46Q34482068-D52EE330-F9F8-4F3A-893F-811F8B782796Q34792888-E9C44C27-462F-4691-A0E4-1385F43E816EQ34930997-3F189286-5412-45B3-A0F1-E6EE3B5B9C2EQ35092268-F776CE2D-9732-4999-BE7E-07FDE8DEAC18Q35532349-EB687DA4-61B7-4903-AB00-BF285C0F5261Q35640721-D06BC2D8-9C63-436C-8FA7-BC989455C057Q35795850-0AFC7451-4EA0-42E2-9B2F-5F8D925BF136Q35995255-CBB1D5E2-B167-404B-A0CF-7E117BF8CC02Q36264598-34D1C203-64CA-419B-8588-21B85491FDDEQ38608835-C6111A84-389F-42B9-8997-701BF593EED9Q38720041-3795C232-92A0-43DC-8FBA-2B2D80A7EA89Q39730948-F47D8613-B701-43B7-9A2C-15F33F422B66Q42717234-409FC60D-116A-4435-B039-F7E638A208A6Q44813921-7AF65589-E918-4144-82E8-9D1F05AF8F36Q51917151-5621CBC9-D4BE-4790-94A2-C6EC11B9F27DQ53258569-F4EF8D21-8F00-4778-BDC8-93CF98FA106EQ56915997-4307B418-BF5C-4782-AB52-F15501BB94B4
P2860
Diversity screening versus focussed screening in drug discovery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Diversity screening versus focussed screening in drug discovery.
@ast
Diversity screening versus focussed screening in drug discovery.
@en
type
label
Diversity screening versus focussed screening in drug discovery.
@ast
Diversity screening versus focussed screening in drug discovery.
@en
prefLabel
Diversity screening versus focussed screening in drug discovery.
@ast
Diversity screening versus focussed screening in drug discovery.
@en
P1433
P1476
Diversity screening versus focussed screening in drug discovery.
@en
P2093
P304
P356
10.1016/S1359-6446(00)01517-8
P577
2000-07-01T00:00:00Z